Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2011; 17(14): 1858-1865
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1858
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1858
Figure 3 Median total (A), acid reflux (B) and dysmotility (C) Frequency scale for the symptoms of gastroesophageal reflux disease scores.
Frequency scale for the symptoms of gastroesophageal reflux disease scores in RPZ(20), RPZ(20*2), and RPZ(10*4) regimens significantly improved compared with that at baseline and RPZ(10). aP < 0.05 [vs baseline (10) ]; cP < 0.05 [vs RP (10) ]; eP < 0.05 [vs RP (20) ]. RPZ: Rabeprazole; FSSG: Frequency scale for the symptoms of gastroesophageal reflux disease.
- Citation: Sugimoto M, Nishino M, Kodaira C, Yamade M, Uotani T, Ikuma M, Umemura K, Furuta T. Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy. World J Gastroenterol 2011; 17(14): 1858-1865
- URL: https://www.wjgnet.com/1007-9327/full/v17/i14/1858.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i14.1858